BioLineRx Ltd. — Capital/Financing Update 2012

Feb 27, 2012

6-K 1 v303962_6k.htm FORM 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2012

---

BioLineRx Ltd.

(Translation of Registrant’s name into English)

---

P.O. Box 45158 19 Hartum Street Jerusalem 91450, Israel

(Address of Principal Executive Offices)

---

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F þ Form 40-F o

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: Yes o No þ

---

Field: Page; Sequence: 1

1

Field: /Page

BioLineRx Ltd. (the "Company") announced today that on February 22, 2012, it closed its previously announced $15 million private placement to healthcare-focused U.S. institutional investors. As a result, the Company sold 5.25 million American Depositary Shares (“ADSs”) at a purchase price of $2.86 per ADS, and warrants to purchase up to 2.6 million additional ADSs at an exercise price of $3.57 per ADS. After fees and estimated offering expenses, the Company received net proceeds of $14.1 million.

A copy of the press release announcing the closing of the transaction is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Field: Page; Sequence: 2

2

Field: /Page

Exhibit Index

Exhibit 99.1 Press release dated February 27, 2012

Field: Page; Sequence: 3

3

Field: /Page

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BioLineRx Ltd.
By:	/s/ Philip Serlin
	Philip Serlin
	Chief Financial and Operating Officer

Date: February 27, 2012

Field: Page; Sequence: 4; Options: Last

4

Field: /Page